NLRP3 and malignant colon neoplasm: The role of NLRP3 in colon cancer has been controversial with studies showing that high expression of NLRP3 drives epithelial-mesenchymal transition (EMT) (Shao et al. 2020) and results in poor survival (Shi et al. 2021).